Y-shape pegylated somatropin
Small molecule
Y-shape pegylated somatropin is one of 35 small molecule programs targeting Growth Hormone Deficiency. It is currently in development.
1
Indications
1
Total Trials
0
Active Trials
34
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
51 competitors in Growth Hormone Deficiency
#DrugCompanyPhaseTrials
1Genotropin
EMD SeronoApproved
Nutropin AQ
RocheApproved
Recombinant Human Growth Hormone
Changchun GeneScience Pharmaceutical Co., Ltd.Approved
Saizen
Merck & Co.Phase 3
PEG-Somatropin
Changchun GeneScience Pharmaceutical Co., Ltd.Approved
Norditropin
Novo NordiskPhase 3
Macrilen
AAEterna Zentaris
Phase 3
Genotropin
PfizerPhase 2
LUM-201
LLumos Pharma
Phase 3
Human Growth Hormone
AAscendis Pharma A/S
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company
- XXiamen Amoytop Biotech Co., Ltd.